Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Jerome

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Ecstasy use-Parkinson's disease link tenuousLisa Jerome, Rick Doblin, Michael Mithoefer
Science (New York, N.Y.)|June 7, 2003
MDMA ("ecstasy") and neurotoxicityMichael Mithoefer, Lisa Jerome, Richard Doblin
The New England Journal of Medicine|November 3, 2017
Post-Traumatic Stress DisorderMichael C Mithoefer, Lisa Jerome, Candice Monson
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasyHarry R Sumnall, Jon C Cole, Lisa Jerome
Journal of Psychoactive Drugs|May 17, 2014
History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS)Amy Emerson, Linnae Ponté, Lisa Jerome, et al.
Current Drug Abuse Reviews|May 1, 2013
Can MDMA play a role in the treatment of substance abuse?Lisa Jerome, Shira Schuster, B Berra Yazar-Klosinski
Frontiers in Psychiatry|February 10, 2022
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS DatabaseTigran Makunts, Lisa Jerome, Ruben Abagyan, et al.
Journal of Psychoactive Drugs|May 29, 2019
The Past and Future of Psychedelic Science: An Introduction to This IssueRichard E Doblin, Merete Christiansen, Lisa Jerome, et al.
Drug and Alcohol Dependence|January 25, 2005
Is ecstasy perceived to be safe? A critical surveyAlex Gamma, Lisa Jerome, Matthias E Liechti, et al.
Psychopharmacology|November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Ecstasy use-Parkinson's disease link tenuousLisa Jerome, Rick Doblin, Michael Mithoefer
Science (New York, N.Y.)|June 7, 2003
MDMA ("ecstasy") and neurotoxicityMichael Mithoefer, Lisa Jerome, Richard Doblin
The New England Journal of Medicine|November 3, 2017
Post-Traumatic Stress DisorderMichael C Mithoefer, Lisa Jerome, Candice Monson
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasyHarry R Sumnall, Jon C Cole, Lisa Jerome
Journal of Psychoactive Drugs|May 17, 2014
History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS)Amy Emerson, Linnae Ponté, Lisa Jerome, et al.
Current Drug Abuse Reviews|May 1, 2013
Can MDMA play a role in the treatment of substance abuse?Lisa Jerome, Shira Schuster, B Berra Yazar-Klosinski
Frontiers in Psychiatry|February 10, 2022
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS DatabaseTigran Makunts, Lisa Jerome, Ruben Abagyan, et al.
Journal of Psychoactive Drugs|May 29, 2019
The Past and Future of Psychedelic Science: An Introduction to This IssueRichard E Doblin, Merete Christiansen, Lisa Jerome, et al.
Drug and Alcohol Dependence|January 25, 2005
Is ecstasy perceived to be safe? A critical surveyAlex Gamma, Lisa Jerome, Matthias E Liechti, et al.
Psychopharmacology|November 22, 2020
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapyAllison A Feduccia, Lisa Jerome, Michael C Mithoefer, et al.
Pageof 4